| Literature DB >> 27207665 |
Bryan A Bassig, Luoping Zhang1, Roel Vermeulen2, Xiaojiang Tang3, Guilan Li4, Wei Hu, Weihong Guo1, Mark P Purdue, Songnian Yin4, Stephen M Rappaport1, Min Shen, Zhiying Ji1, Chuangyi Qiu3, Yichen Ge3, H Dean Hosgood5, Boris Reiss6, Banghua Wu3, Yuxuan Xie3, Laiyu Li3, Fei Yue3, Laura E Beane Freeman, Aaron Blair, Richard B Hayes7, Hanlin Huang3, Martyn T Smith1, Nathaniel Rothman, Qing Lan.
Abstract
Benzene, formaldehyde (FA) and trichloroethylene (TCE) are ubiquitous chemicals in workplaces and the general environment. Benzene is an established myeloid leukemogen and probable lymphomagen. FA is classified as a myeloid leukemogen but has not been associated with non-Hodgkin lymphoma (NHL), whereas TCE has been associated with NHL but not myeloid leukemia. Epidemiologic associations between FA and myeloid leukemia, and between benzene, TCE and NHL are, however, still debated. Previously, we showed that these chemicals are associated with hematotoxicity in cross-sectional studies of factory workers in China, which included extensive personal monitoring and biological sample collection. Here, we compare and contrast patterns of hematotoxicity, monosomy 7 in myeloid progenitor cells (MPCs), and B-cell activation biomarkers across these studies to further evaluate possible mechanisms of action and consistency of effects with observed hematologic cancer risks. Workers exposed to benzene or FA, but not TCE, showed declines in cell types derived from MPCs, including granulocytes and platelets. Alterations in lymphoid cell types, including B cells and CD4+ T cells, and B-cell activation markers were apparent in workers exposed to benzene or TCE. Given that alterations in myeloid and lymphoid cell types are associated with hematological malignancies, our data provide biologic insight into the epidemiological evidence linking benzene and FA exposure with myeloid leukemia risk, and TCE and benzene exposure with NHL risk. Published by Oxford University Press 2016.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27207665 PMCID: PMC4936387 DOI: 10.1093/carcin/bgw053
Source DB: PubMed Journal: Carcinogenesis ISSN: 0143-3334 Impact factor: 4.944